Indivior PLC | Mutual Funds
Mutual Funds that own Indivior PLC
Old Mutual Invt. Funds Series I - UK Mid Cap Fund
20,395,076
2.8%
5,283,340
1.78%
09/29/2017
Government Pension Fund - Global (The)
20,374,131
2.8%
5,350,679
0.01%
12/31/2017
Artemis Income Fund
18,729,294
2.57%
0
0.85%
06/29/2018
Fidelity Low Priced Stock Fund
16,623,938
2.27%
-327,155
0.17%
04/30/2018
Fidelity Diversified International Fund
12,028,300
1.65%
-261,900
0.26%
07/31/2018
Vanguard Total International Stock Index Fund
10,225,680
1.4%
115,832
0.01%
07/31/2018
Invesco Funds - Pan European Structured Equity Fund
7,844,844
1.08%
0
0.42%
03/29/2018
Janus Global Life Sciences Fund
6,872,434
0.94%
558,531
0.59%
06/30/2018
St. James's Place Unit Trust - UK & International Income
6,783,176
0.93%
866,052
0.81%
03/31/2018
Fidelity Select Health Care Portfolio
6,200,000
0.85%
65,491
0.28%
07/31/2018
| Address |
103-105 Bath Road
Slough Berkshire SL1 3UH
United Kingdom
|
|
Employees
|
- |
| Website |
http://indivior.com/ |
| Updated |
07/08/2019 |
| Indivior PLC is a holding company, which engages in the manufacture and distribution of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, Subutex Tablet, and Sublocade Injection. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom. |
